Intuitive Surgical, Inc. (NASDAQ:ISRG)‘s stock had its “outperform” rating reiterated by equities research analysts at Leerink Swann in a research report issued on Saturday, April 22nd. They presently have a $850.00 price target on the medical equipment provider’s stock, up from their previous price target of $840.00. Leerink Swann’s price target would suggest a potential downside of 2.34% from the stock’s current price.
A number of other research analysts also recently issued reports on the stock. Canaccord Genuity reaffirmed a “buy” rating and issued a $800.00 price objective on shares of Intuitive Surgical in a research report on Friday, March 24th. Evercore ISI downgraded shares of Intuitive Surgical from a “buy” rating to a “hold” rating and set a $690.00 price objective on the stock. in a research report on Wednesday, January 4th. Royal Bank of Canada lifted their price objective on shares of Intuitive Surgical from $720.00 to $770.00 and gave the stock a “sector perform” rating in a research report on Monday, April 17th. Barclays PLC reaffirmed a “buy” rating and issued a $800.00 price objective on shares of Intuitive Surgical in a research report on Sunday, March 26th. Finally, Zacks Investment Research downgraded shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Tuesday, January 17th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and twelve have issued a buy rating to the stock. Intuitive Surgical has a consensus rating of “Buy” and a consensus target price of $816.64.
Shares of Intuitive Surgical (NASDAQ:ISRG) traded up 1.20% during trading on Friday, reaching $870.33. 415,283 shares of the company traded hands. Intuitive Surgical has a 12-month low of $610.71 and a 12-month high of $874.54. The stock has a market capitalization of $32.06 billion, a P/E ratio of 43.87 and a beta of 0.55. The firm’s 50 day moving average is $814.31 and its 200-day moving average is $716.19.
Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, April 18th. The medical equipment provider reported $5.09 EPS for the quarter, beating the consensus estimate of $3.97 by $1.12. Intuitive Surgical had a net margin of 27.21% and a return on equity of 14.24%. The business had revenue of $674.20 million during the quarter, compared to analyst estimates of $664.72 million. During the same quarter in the previous year, the business posted $4.42 EPS. The company’s quarterly revenue was up 13.4% compared to the same quarter last year. On average, equities research analysts anticipate that Intuitive Surgical will post $23.61 earnings per share for the current fiscal year.
In other Intuitive Surgical news, SVP Mark J. Meltzer sold 8,750 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, February 21st. The shares were sold at an average price of $724.82, for a total transaction of $6,342,175.00. Following the completion of the sale, the senior vice president now directly owns 2,274 shares in the company, valued at approximately $1,648,240.68. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, VP Jamie Samath sold 48 shares of Intuitive Surgical stock in a transaction that occurred on Friday, May 5th. The shares were sold at an average price of $850.00, for a total transaction of $40,800.00. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 71,778 shares of company stock valued at $56,370,272. Company insiders own 3.10% of the company’s stock.
A number of hedge funds have recently made changes to their positions in the stock. Guardian Life Insurance Co. of America boosted its position in Intuitive Surgical by 2.2% in the first quarter. Guardian Life Insurance Co. of America now owns 142 shares of the medical equipment provider’s stock valued at $109,000 after buying an additional 3 shares in the last quarter. Acropolis Investment Management LLC purchased a new position in Intuitive Surgical during the first quarter valued at about $115,000. Parallel Advisors LLC boosted its position in Intuitive Surgical by 10.1% in the first quarter. Parallel Advisors LLC now owns 153 shares of the medical equipment provider’s stock valued at $129,000 after buying an additional 14 shares in the last quarter. Huntington National Bank boosted its position in Intuitive Surgical by 14.1% in the first quarter. Huntington National Bank now owns 170 shares of the medical equipment provider’s stock valued at $130,000 after buying an additional 21 shares in the last quarter. Finally, Bessemer Group Inc. boosted its position in Intuitive Surgical by 96.0% in the fourth quarter. Bessemer Group Inc. now owns 196 shares of the medical equipment provider’s stock valued at $124,000 after buying an additional 96 shares in the last quarter. Institutional investors and hedge funds own 91.16% of the company’s stock.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
What are top analysts saying about Intuitive Surgical Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Intuitive Surgical Inc. and related companies.